IP Library › Granted Patent US 12,509,660
Granted Patent B2
US 12,509,660 · App. 17/536,807 · Granted Dec 30, 2025

SOX9-induced oligodendrocyte progenitor cells

Inventors: Hon Man Alex Ng (Cambridge, MA); Parastoo Khoshakhlagh (Cambridge, MA); George M. Church (Cambridge, MA)
Assignee: President and Fellows of Harvard College
C12N5/0622A61K35/30C12N9/1241C12N15/85C12N15/90C12N2501/231C12N2501/24C12N2501/60C12N2506/45
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,509,660
App. No.
17/536,807
Granted
Dec 30, 2025
Kind
B2
Abstract

Provided herein is a differentiation agent that consists essentially of SOX9 for the production of oligodendrocyte progenitor cells (OPCs) from pluripotent stem cells (PSC). Also provided herein are methods of producing the PSCs and methods of using the PSCs to produce OPCs and oligodendrocytes.

Claims (20)

1 . A pluripotent stem cell (PSC) comprising an engineered nucleic acid encoding a transcription factor consisting of SOX9 at a level sufficient to differentiate the PSC into an oligodendrocyte progenitor cell (OPC), wherein the OPC expresses one or more OPC markers at a level sufficient for the PSC to perform one or more OPC functions.

2 . The PSC of claim 1 , wherein the one or more OPC markers comprises O4, NG2, or both.

3 . The PSC of claim 1 , wherein the one or more OPC markers are expressed in less than 10 days from expression of the engineered nucleic acid encoding SOX9 in the PSC.

4 . The PSC of claim 1 , wherein the OPC displays an increase in the number of myelinated axons by at least two-fold.

5 . A population of pluripotent stem cells (PSCs) comprising at least one engineered nucleic acid encoding a transcription factor consisting of SOX9 at a level sufficient upon induction to reprogram the population of PSCs directly into oligodendrocyte progenitor cells (OPCs).

6 . The population of claim 5 , wherein the OPCs express one or more OPC markers.

7 . The population of claim 6 , wherein the one or more OPC markers comprises O4, NG2, or both.

8 . The population of claim 6 , wherein the one or more OPC markers are expressed in less than 10 days from expression of the at least one engineered nucleic acid encoding SOX9.

9 . The population of claim 6 , wherein at least 40% of the OPCs express at least one marker of the one or more OPC markers.

10 . The population of claim 5 , wherein the OPCs display an increase in the number of myelinated axons by at least two-fold.

11 . The population of claim 5 , wherein at least 30%, at least 40%, at least 50%, or at least 60% of the OPCs express O4, NG2, or both.

12 . The PSC of claim 1 , wherein the OPC expresses a mature myelin marker.

13 . The PSC of claim 1 , wherein the one or more OPC functions comprises forming myelin.

14 . The PSC of claim 1 , wherein the one or more OPC functions comprises secreting a cytokine.

15 . The PSC of claim 1 , wherein the engineered nucleic acid encoding SOX9 is a PiggyBac vector.

16 . The PSC of claim 1 , wherein the engineered nucleic acid encoding SOX9 is operably linked to an inducible promoter.

17 . The PSC of claim 1 , wherein the OPC expresses at least one oligodendrocyte gene, wherein the at least one oligodendrocyte gene comprises one or more of: Myelin Basic Protein (MBP), NK2 Homeobox 1 (NKX2-1), Myelin Oligodendrocyte Glycoprotein (MOG), Myelin Associated Oligodendrocyte Basic Protein (MOBP), OLIG2 (Oligodendrocyte Transcription Factor 2), Chondroitin Sulfate Proteoglycan 4 (CSPG4), Oligodendrocyte Transcription Factor 1 (OLIG1), SRY-Box Transcription Factor 8 (SOX8), SRY-Box Transcription Factor 10 (SOX10), Myelin Regulatory Factor (MYRF), Platelet Derived Growth Factor Receptor Alpha (PDGFRA), Matrix Metallopeptidase 15 (MMP15), Proteolipid Protein 1 (PLP1), Transmembrane Protein 88B (TMEM88B), Ectonucleotide Pyrophosphatase/Phosphodiesterase 6 (ENPP6), and Neurofascin (NFASC).

18 . The PSC of claim 1 , wherein at least one pluripotency gene is down-regulated in the OPC and comprises one or more of: Myelin Regulatory Factor (MYRF), POU Class 5 Homeobox 1 (POU5F1), Nanog Homeobox (NANOG), and SRY-Box Transcription Factor 2 (SOX2).

19 . The population of claim 5 , wherein the PSCs comprise a population average of less than 20 copies of the at least one engineered nucleic acid encoding SOX9.

20 . The population of claim 5 , wherein the OPCs express at least one oligodendrocyte gene, wherein the at least one oligodendrocyte gene comprises one or more of: Myelin Basic Protein (MBP), NK2 Homeobox 1 (NKX2-1), Myelin Oligodendrocyte Glycoprotein (MOG), Myelin Associated Oligodendrocyte Basic Protein (MOBP), OLIG2 (Oligodendrocyte Transcription Factor 2), Chondroitin Sulfate Proteoglycan 4 (CSPG4), Oligodendrocyte Transcription Factor 1 (OLIG1), SRY-Box Transcription Factor 8 (SOX8), SRY-Box Transcription Factor 10 (SOX10), Myelin Regulatory Factor (MYRF), Platelet Derived Growth Factor Receptor Alpha (PDGFRA), Matrix Metallopeptidase 15 (MMP15), Proteolipid Protein 1 (PLP1), Transmembrane Protein 88B (TMEM88B), Ectonucleotide Pyrophosphatase/Phosphodiesterase 6 (ENPP6), and Neurofascin (NFASC).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2022
From: NG, HON MAN ALEX; KHOSHAKHLAGH, PARASTOO; CHURCH, GEORGE M.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 060534/0714 →
Continuity (3)
Continuation PCTUS2020035069 · May 29, 2020
Provisional Application 62855135 · May 31, 2019
Related Publication 20220204926A1 · Jun 30, 2022
References Cited (197)
US 7812124B2 · Palm · 2010 [cited by applicant]
US 9057053B2 · Wernig et al. · 2015 [cited by applicant]
US 9273119B2 · Maizels et al. · 2016 [cited by applicant]
US 9487757B2 · Tesar et al. · 2016 [cited by applicant]
US 9732128B2 · West et al. · 2017 [cited by applicant]
US 11788131B2 · Ng et al. · 2023 [cited by applicant]
US 11845960B2 · Ng et al. · 2023 [cited by applicant]
US 12031153B2 · Khoshakhlagh · 2024 [cited by examiner]
US 12195756B2 · Khoshakhlagh · 2025 [cited by examiner]
US 20030092009A1 · Palm · 2003 [cited by applicant]
US 20040219575A1 · Neuman et al. · 2004 [cited by applicant]
US 20070161023A1 · Palm · 2007 [cited by applicant]
US 20090176724A1 · Shen et al. · 2009 [cited by applicant]
US 20100093092A1 · Bamdad et al. · 2010 [cited by applicant]
US 20100159595A1 · Zhang et al. · 2010 [cited by applicant]
US 20110154518A1 · Kim et al. · 2011 [cited by applicant]
US 20120070419A1 · Christiansen-Weber · 2012 [cited by applicant]
US 20120107284A1 · Kozlova · 2012 [cited by applicant]
US 20120129262A1 · West et al. · 2012 [cited by applicant]
US 20120157474A1 · Dreyfuss et al. · 2012 [cited by applicant]
US 20120207744A1 · Mendlein et al. · 2012 [cited by applicant]
US 20130022583A1 · Wernig et al. · 2013 [cited by applicant]
US 20130029423A1 · Yamanaka et al. · 2013 [cited by applicant]
US 20130160152A1 · Ostertag et al. · 2013 [cited by applicant]
US 20130309769A1 · Benvenisty et al. · 2013 [cited by applicant]
US 20130330825A1 · Couture et al. · 2013 [cited by applicant]
US 20140170752A1 · Pulst et al. · 2014 [cited by applicant]
US 20140234971A1 · Slukvin et al. · 2014 [cited by applicant]
US 20150044187A1 · Visel et al. · 2015 [cited by applicant]
US 20150284681A1 · Wernig et al. · 2015 [cited by applicant]
US 20150352154A1 · Goldman et al. · 2015 [cited by applicant]
US 20160010056A1 · Nakaki et al. · 2016 [cited by applicant]
US 20160038544A1 · Keller et al. · 2016 [cited by applicant]
US 20160201053A1 · Maizels et al. · 2016 [cited by applicant]
US 20160237402A1 · Tilly et al. · 2016 [cited by applicant]
US 20170087192A1 · Tilly et al. · 2017 [cited by applicant]
US 20180127714A1 · Ko · 2018 [cited by applicant]
US 20180289748A9 · Tilly et al. · 2018 [cited by applicant]
US 20190017032A1 · Firas et al. · 2019 [cited by applicant]
US 20190099452A1 · Jiang et al. · 2019 [cited by applicant]
US 20190233795A1 · Ng et al. · 2019 [cited by applicant]
US 20200063105A1 · Ng et al. · 2020 [cited by applicant]
US 20210054448A1 · Ng et al. · 2021 [cited by applicant]
US 20210171902A1 · Khoshakhlagh et al. · 2021 [cited by applicant]
US 20240117312A1 · Ng et al. · 2024 [cited by applicant]
US 20240209321A1 · Ng et al. · 2024 [cited by applicant]
US 20240209435A1 · Ng et al. · 2024 [cited by applicant]
US 20240254437A1 · Khoshakhlagh et al. · 2024 [cited by applicant]
US 20240309318A1 · Khoshakhlagh et al. · 2024 [cited by applicant]
CN 101914492A · 2010 [cited by applicant]
CN 102796696A · 2012 [cited by applicant]
CN 106456672A · 2017 [cited by applicant]
CN 109072200A · 2018 [cited by applicant]
EP 3118306A1 · 2017 [cited by applicant]
JP 2021040578A · 2021 [cited by applicant]
WO WO2004060302A2 · 2004 [cited by applicant]
WO WO2006005043A2 · 2006 [cited by applicant]
WO WO2008153568A1 · 2008 [cited by applicant]
WO WO2009029315A2 · 2009 [cited by applicant]
WO WO2009029315A9 · 2009 [cited by applicant]
WO WO2009137674A2 · 2009 [cited by applicant]
WO WO2009137844A2 · 2009 [cited by applicant]
WO WO2011091048A1 · 2011 [cited by applicant]
WO WO2012054896A1 · 2012 [cited by applicant]
WO WO2013124309A1 · 2013 [cited by applicant]
WO WO2013170146A1 · 2013 [cited by applicant]
WO WO2015049677A1 · 2015 [cited by applicant]
WO WO2015084908A1 · 2015 [cited by applicant]
WO WO2015179822A1 · 2015 [cited by applicant]
WO WO2016012570A1 · 2016 [cited by applicant]
WO WO2016103269A1 · 2016 [cited by applicant]
WO WO2016120493A1 · 2016 [cited by applicant]
WO WO2016163958A1 · 2016 [cited by applicant]
WO WO2017015075A1 · 2017 [cited by applicant]
WO WO2018049382A1 · 2018 [cited by applicant]
WO WO2018204262A1 · 2018 [cited by applicant]
WO WO2019108894A1 · 2019 [cited by applicant]
WO WO2020243392A1 · 2020 [cited by applicant]
WO WO2020243643A1 · 2020 [cited by applicant]
Moyon et al. Demyelination Causes Adult CNS Progenitors to Revert to an Immature State and Express Immune Cues That Support Their Migration. The Journal of Neuroscience (2015), 35(1), 4-20. (Year: 2015). [cited by examiner]
Bian et al. Sequential Differentiation of Embryonic Stem Cells into Neural Epithelial-Like Stem Cells and Oligodendrocyte Progenitor Cells. PLoS One (2016), 11(5), e1055227; (Year: 2016). [cited by examiner]
Salewski et al. The Generation of Definitive Neural Stem Cells from PiggyBac Transposon-Induced Pluripotent Stem Cells Can Be Enhanced by Induction of the NOTCH Signaling Pathway. Stem Cells and Development (2013), 22(3… [cited by examiner]
Kaji et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature (2009), 458(7239), 771-775. (Year: 2009). [cited by examiner]
Carey et al. Reprogramming of murine and human somatic cells using a single polycistronic vector. PNAS (2009), 106(1), 157-162 plus appended Correction. (Year: 2009). [cited by examiner]
Nishiyama et al. Uncovering Early Response of Gene Regulatory Networks in ESCs by Systematic Induction of Transcription Factors. Cell Stem Cell (2009), 5(4), 420-433. (Year: 2009). [cited by examiner]
International Search Report and Written Opinion for Application No. PCT/US2020/035069, mailed Sep. 9, 2020. [cited by applicant]
International Preliminary Report on Patentability for Application No. PCT/US2020/035069, mailed Dec. 9, 2021. [cited by applicant]
[No Author Listed], Genbank Submission; NIH/NCBI, Accession No. EF587698. Jul. 16, 2007. 2 pages. [cited by applicant]
[No Author Listed], Genbank Submission; NIH/NCBI, Accession No. NM_203289. Dec. 28, 2019. 4 pages. [cited by applicant]
[No Author Listed], Genbank Submission; NIH/NCBI, Accession No. EF687698. Dec. 8, 2016. 1 page. [cited by applicant]
[No Author Listed], Genbank Submission; NIH/NCBI, Accession No. NM_001173531. Dec. 28, 2019. 4 pages. [cited by applicant]
[No Author Listed], Genbank Submission; NIH/NCBI, Accession No. NM_001285986. Dec. 28, 2019. 4 pages. [cited by applicant]
[No Author Listed], Genbank Submission; NIH/NCBI, Accession No. NM_001285987. Dec. 28, 2019. 4 pages. [cited by applicant]
[No Author Listed], Genbank Submission; NIH/NCBI, Accession No. NM_002176. Dec. 31, 2019. 3 pages. [cited by applicant]
[No Author Listed], Genbank Submission; NIH/NCBI, Accession No. NM_002701. Dec. 31, 2019. 5 pages. [cited by applicant]
[No Author Listed], Genbank Submission; NIH/NCBI, Accession No. NM_005806. Sep. 27, 2019. 3 Pages. [cited by applicant]
[No Author Listed], Genbank Submission; NIH/NCBI, Accession No. NM_006168. Aug. 2, 2019. 3 pages. [cited by applicant]
[No Author Listed], Genbank Submission; NIH/NCBI, Accession No. NM_152568. Oct. 23, 2019. 3 pages. [cited by applicant]
[No Author Listed], Genbank Submission; NIH/NCBI, Accession No. NM_177400. Oct. 1, 2019. 3 pages. [cited by applicant]
[No Author Listed], Genbank Submission; NIH/NCBI, Accession No. NM_000572. May 28, 2019. 4 pages. [cited by applicant]
[No Author Listed], Genbank Submission; NIH/NCBI, Accession No. Z46629. Oct. 7, 2008. 3 pages. [cited by applicant]
[No Author Listed], ORFeome Collaboration. The ORFeome Collaboration: a genome-scale human ORF-clone resource. Nat Methods. Mar. 2016; 13(3):191-2. doi: 10.1038/nmeth.3776. [cited by applicant]
Adamson et al., A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response. Cell. Dec. 15, 2016;167(7):1867-1882.e21. doi: 10.1016/j.cell.2016.11.048. [cited by applicant]
Beneviste et al., Type I interferons as anti-inflammatory mediators. Sci STKE. Dec. 11, 200712007(416):pe70. [cited by applicant]
Bi et al., Sox9 is required for cartilage formation. Nat Genet. May 1999;22(1):85-9. [cited by applicant]
Bornsen et al., Endogenous interferon-β-inducible gene expression and interferon-β-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis. PLoS One. Mar. 4, 2015;10(3):e0118… [cited by applicant]
Burdo et al., The Maize TFome—development of a transcription factor open reading frame collection for functional genomics. Plant J. Oct. 2014;80(2):356-66. doi: 10.1111/tpj.12623. Epub Aug. 26, 2014. [cited by applicant]
Busskamp et al., Rapid neurogenesis through transcriptional activation in human stem cells. Mol Syst Biol. Nov. 17, 2014;10:760(1-21). doi: 10.15252/msb.20145508. [cited by applicant]
Cannella et al., Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation. Ann Neurol. Jan. 2004;55(1):46-57. [cited by applicant]
Carstens, Identification and nucleotide sequence of the regions of Autographa californica nuclear polyhedrosis virus genome carrying insertion elements derived from Spodoptera frugiperda. Virology. Nov. 1987;161(1):8-17… [cited by applicant]
Chanda et al., Generation of induced neuronal cells by the single reprogramming factor ASCL1. Stem Cell Reports. Aug. 12, 2014;3(2):282-96. doi: 10.1016/j.stemcr.2014.05.020. Epub Jul. 4, 2014. [cited by applicant]
Chavez et al., Comparative analysis of Cas9 activators across multiple species. Nat Methods. Jul. 2016;13(7):563-567. doi: 10.1038/nmeth.3871. Epub May 23, 2016. Author Manuscript, 16 pages. [cited by applicant]
Chavez et al., Highly efficient Cas9-mediated transcriptional programming. Nat Methods. Apr. 2015;12(4):326-8. doi: 10.1038/nmeth.3312. Epub Mar. 2, 2015. Author Manuscript, 11 pages. [cited by applicant]
Chen et al., Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters. BMC Biotechnol. 2017;17(1):11(1-10). Published Feb. 13, 2017. doi:10.1186/s12896-017-0336-7. [cited by applicant]
Choi et al., A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs. Nat Biotechnol. Nov. 2015;33(11):1173-81. doi: 10.1038/nbt.3388. Epub Oct. 26, 20156 Author Manuscript, 22 pag… [cited by applicant]
Darr et al., Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development. Mar. 2006;133(6):1193-201. [cited by applicant]
Dendrou et al., Immunopathology of multiple sclerosis. Nat Rev Immunol. Sep. 15, 2015;15(9):545-58. doi: 10.1038/nri3871. Epub Aug. 7, 2015. [cited by applicant]
Dixit et al., Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens. Cell. Dec. 15, 2016;167(7):1853-1866.e17. doi: 10.1016/j.cell.2016.11.038. [cited by applicant]
Douvaras et al., Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells. Nat Protoc. Aug. 2015;10(8):1143-54. doi: 10.1038/nprot.2015.075. Epub Jul. 2, 2015. [cited by applicant]
Ehrlich et al., Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors. Proc Natl Acad Sci U S A. Mar. 14, 2017;114(11):E2243-E2252. doi: 10.1073/pnas.16… [cited by applicant]
Fraser et al., Acquisition of Host Cell DNA Sequences by Baculoviruses: Relationship Between Host DNA Insertions and FP Mutants of Autographa californica and Galleria mellonella Nuclear Polyhedrosis Viruses. J Virol. Au… [cited by applicant]
Garcia-Leon et al., SOX10 Single Transcription Factor-Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells. Stem Cell Reports. Feb. 13, 2018;10(2):655-672. doi: 10.1016/j.stemcr.2017… [cited by applicant]
Gohl et al., Large-scale mapping of transposable element insertion sites using digital encoding of sample identity. Genetics. Mar. 2014;196(3):615-23. doi: 10.1534/genetics.113.159483. Epub Dec. 27, 2013. [cited by applicant]
Goldman et al., How to make an oligodendrocyte. Development. Dec. 1, 2015;142(23):3983-95. doi: 10.1242/dev.126409. [cited by applicant]
Goparaju et al., Rapid differentiation of human pluripotent stem cells into functional neurons by mRNAs encoding transcription factors. Sci Rep. Feb. 13, 2017;7:42367(1-12). doi: 10.1038/srep42367. [cited by applicant]
Gorbacheva et al., Improved transposon-based library preparation for the Ion Torrent platform. Biotechniques. Apr. 1, 2015;58(4):200-2. doi: 10.2144/000114277. [cited by applicant]
Gorris et al., Pluripotent stem cell-derived radial glia-like cells as stable intermediate for efficient generation of human oligodendrocytes. Glia. Dec. 2015;63(12):2152-67. doi: 10.1002/glia.22882. Epub Jun. 30, 2015. [cited by applicant]
Gradwohl et al., neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci U S A. Feb. 15, 2000;97(4):1607-11. [cited by applicant]
Haenebalcke et al., The ROSA26-iPSC mouse: a conditional, inducible, and exchangeable resource for studying cellular (De)differentiation. Cell Rep. Feb. 21, 2013;3(2):335-41. doi: 10.1016/j.celrep.2013.01.016. Epub Feb.… [cited by applicant]
Hou et al., Sleeping Beauty transposon system for genetic etiological research and gene therapy of cancers. Cancer Biol Ther. 2015;16(1):8-16. doi: 10.4161/15384047.2014.986944. [cited by applicant]
Hsieh et al., PKCalpha expression regulated by Elk-1 and MZF-1 in human HCC cells. Biochem Biophys Res Commun. 2006;339(1):217-225. doi:10.1016/j.bbrc.2005.11.015. [cited by applicant]
Hui et al., Isolation and functional characterization of the human gene encoding the myeloid zinc finger protein MZF-1. Biochemistry. 1995;34(50):16493-16502. doi:10.1021/bi00050a033. [cited by applicant]
Ivics et al., Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell. Nov. 14, 1997;91(4):501-10. doi: 10.1016/s0092-8674(00)80436-5. [cited by applicant]
Jaitin et al., Dissecting Immune Circuits by Linking CRISPR-Pooled Screens with Single-Cell RNA-Seq. Cell. Dec. 15, 2016;167(7):1883-1896.e15. doi: 10.1016/j.cell.2016.11.039. [cited by applicant]
Kim et al., Oct4-induced oligodendrocyte progenitor cells enhance functional recovery in spinal cord injury model. Embo J. Oct. 23, 2015334(23):2971-83. [cited by applicant]
Klein et al., Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells. Cell. May 21, 2015;161(5):1187-1201 and Supplemental Info. doi: 10.1016/j.cell.2015.04.044. [cited by applicant]
Klose et al., Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem/progenitor cells. J Neuroinflammation. Sep. 22, 2013;10:117. doi: 10.1186/1742-2094-10-117. [cited by applicant]
Levy et al., mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation. Blood. Oct. 3, 2013;122(14):e23-32. doi: 10.1182/blood-2013-04-495119. Epub Aug. 26, 2013. [cited by applicant]
Li et al., Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity. Mol Ther. Aug. 2016;24(8):1456-69. doi: 10.1038/mt.2016.104. Epub May 16, 2016. [cited by applicant]
Liao et al., Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis. Biomaterials. Jan. 2016;77:87-97. doi: 10.101… [cited by applicant]
Macosko et al., Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets. Cell. May 21, 2015;161(5):1202-1214. doi: 10.1016/j.cell.2015.05.002. [cited by applicant]
Makar et al., Stem cell based delivery of IFN-beta reduces relapses in experimental autoimmune encephalomyelitis. J Neuroimmunol. May 30, 2008;196(1-2):67-81. doi: 10.1016/j.jneuroim.2008.02.014. Epub May 8, 2008. [cited by applicant]
Mohammadzadeh et al., Evaluation of AD-MSC (adipose-derived mesenchymal stem cells) as a vehicle for IFN-β delivery in experimental autoimmune encephalomyelitis. Clin Immunol. Aug. 2016;169:98-106. doi: 10.1016/j.clim.2… [cited by applicant]
Morris et al., The myeloid zinc finger gene, MZF-1, regulates the CD34 promoter in vitro. Blood. 1995;86(10):3640-3647. [cited by applicant]
Mulvaney et al., Atoh1, an essential transcription factor in neurogenesis and intestinal and inner ear development: function, regulation, and context dependency. J Assoc Res Otolaryngol. Jun. 2012;13(3):281-93. doi: 10.… [cited by applicant]
Najm et al., Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells. Nat Biotechnol. May 2013;31(5):426-33. doi: 10.1038/nbt.2561. Epub Apr. 14, 2013. [cited by applicant]
Neman et al., A method for deriving homogenous population of oligodendrocytes from mouse embryonic stem cells. Dev Neurobiol. Jun. 2012;72(6):777-88. doi: 10.1002/dneu.22008. [cited by applicant]
Ng, Differentiation of Human Cells and Tissues Using a Comprehensive Human Transcription Factor Library. Doctoral dissertation, Harvard University, Graduate School of Arts & Sciences. 2018. Retrieved from https://dash.h… [cited by applicant]
Nishiyama et al., Uncovering early response of gene regulatory networks in ESCs by systematic induction of transcription factors. Cell Stem Cell. Oct. 2, 2009;5(4):420-33. doi: 10.1016/j.stem.2009.07.012. Author Manuscr… [cited by applicant]
Opal et al., Anti-inflammatory cytokines. Chest. Apr. 2000;117(4):1162-72. [cited by applicant]
Pagliuca et al., Generation of functional human pancreatic β cells in vitro. Cell. Oct. 9, 2014;159(2):428-39. doi: 10.1016/j.cell.2014.09.040. Author Manuscript, 29 pages. [cited by applicant]
Pashai et al., Genome-wide profiling of pluripotent cells reveals a unique molecular signature of human embryonic germ cells. PLoS One. 2012;7(6):e39088(1-19). doi:10.1371/journal.pone.0039088. [cited by applicant]
Perrotti et al., Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and c-myb promoter activity. Mol Cell Biol. 1995… [cited by applicant]
Rukstalis et al., Neurogenin3: a master regulator of pancreatic islet differentiation and regeneration. Islets. Nov.-Dec 2009;1(3):177-84. doi: 10.4161/isl.1.3.9877. [cited by applicant]
Sagal et al., Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons. Stem Cells Transl Med. Aug. 2014;3(8):888-98. doi: 10.5966/sctm.2013-… [cited by applicant]
Selvaraj et al., Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies. Trends Biotechnol. Apr. 2010;28(4):214-23. doi: 10.1016/j.tibtech.2010.01.002. Epub Feb… [cited by applicant]
Simicevic et al., Absolute quantification of transcription factors during cellular differentiation using multiplexed targeted proteomics. Nat Methods. Jun. 2013;10(6):570-6. doi: 10.1038/nmeth.2441. Epub Apr. 14, 2013. [cited by applicant]
Singari et al., Singari S, Javeed N, Tardi NJ, Marada S, Carlson JC, Kirk S, Thorn JM, Edwards KA. Inducible protein traps with dominant phenotypes for functional analysis of the [cited by applicant]
Sripal, Combined expression of microRNAs and transcription factors for promoting hair cell differentiation. 2013 Master's Thesis. Department of Biomedical Sciences. Creighton University, 89 pages. Submitted Jul. 29, 201… [cited by applicant]
Stolt et al., The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev. Jul. 1, 2003;17(13):1677-89. [cited by applicant]
Suchorska et al., Comparison of Four Protocols to Generate Chondrocyte-Like Cells from Human Induced Pluripotent Stem Cells (hiPSCs). Stem Cell Rev Rep. Apr. 2017;13(2):299-308. doi: 10.1007/s12015-016-9708-y. [cited by applicant]
Takahashi et al., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. Aug. 25, 2006;126(4):663-76. Epub Aug. 10, 2006. [cited by applicant]
Trandem et al., Virally expressed interleukin-10 ameliorates acute encephalomyelitis and chronic demyelination in coronavirus-infected mice. J Virol. Jul. 2011;85(14):6822-31. doi: 10.1128/JVI.00510-11. Epub May 18, 201… [cited by applicant]
Trounson, Pluripotent stem cells progressing to the clinic. Nat Rev Mol Cell Biol. Mar. 2016; 17(3):194-200. doi: 10.1038/nrm.2016.10. [cited by applicant]
Van Der Maaten et al., Visualizing Data using t-SNE. J Mach Learn Res. 2008;9(86):2579-2605. [cited by applicant]
Vaquerizas et al., A census of human transcription factors: function, expression and evolution. Nat Rev Genet. Apr. 2009;10(4):252-63. doi: 10.1038/nrg2538. [cited by applicant]
Walczak et al., Directed differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6.1 factors in IPC progenitors. J Transl Med. Dec. 20, 2016;14(1):341. doi: 10.1186/s1… [cited by applicant]
Wang et al., Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell. Feb. 7, 2013;12(2):252-64. doi: 10.1016/j.stem.2012.12.002. [cited by applicant]
Williams et al., SnapShot: directed differentiation of pluripotent stem cells. Cell. May 25, 2012;149(5):1174-1174.e1. doi: 10.1016/j.cell.2012.05.015. 2 pages. [cited by applicant]
Xiao et al., Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis. Int J Mol Sci. Apr. 24, 2015;16(5):9283-302. doi: 10.3390/ijms16059283. [cited by applicant]
Yamakawa et al., Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency. Stem Cells. Nov. 2016;34(11):2661-2669. doi: 10.10… [cited by applicant]
Yamamizu et al., Identification of transcription factors for lineage-specific ESC differentiation. Stem Cell Reports. Dec. 2013;1(6):545-59. doi: 10.1016/j.stemcr.2013.10.006. eCollection 2013. [cited by applicant]
Yamanaka, Induced pluripotent stem cells: past, present, and future. Cell Stem Cell. Jun. 14, 2012;10(6):678-684. doi: 10.1016/j.stem.2012.05.005. [cited by applicant]
Yang et al., Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis. J Clin Invest. Dec. 2009;119(12):3678-91. doi: 10.1172/JCI37914. Epub Nov. … [cited by applicant]
Yang et al., Generation of oligodendroglial cells by direct lineage conversion. Nat Biotechnol. May 2013;31(5):434-9. doi: 10.1038/nbt.2564. Epub Apr. 14, 2013. [cited by applicant]
Zhang et al., Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron. Jun. 5, 2013;78(5):785-98. doi: 10.1016/j.neuron.2013.05.029. [cited by applicant]
[No Author Listed], Genbank Submission; NIH/NCBI, Accession No. NM_000572.2. Nov. 20, 2017. 3 pages. [cited by applicant]
[No Author Listed], Origene, Product datasheet for RC211285L1, BAPX1 (NKX3-2) (NM_001189) Human Tagged ORF Clone. Retrieved Nov. 15, 2022. https://www.origene.com/catalog/cdna-clones/expression-plasmids/rc21128511/bapx1… [cited by applicant]
Abed et al., Transplantation of macaca cynomolgus iPS-derived hematopoietic cells in NSG immunodeficient mice. Haematologica. Oct. 2015;100(10):e428-31. Epub Jun. 18, 2015. [cited by applicant]
Benabdellah et al., Development of an all-in-one lentiviral vector system based on the original TetR for the easy generation of Tet-ON cell lines. PLoS One. 2011;6(8):e23734. Epub Aug. 18, 2011. [cited by applicant]
Cao et al., Restoring BMP4 expression in vascular endothelial progenitors ameliorates maternal diabetes-induced apoptosis and neural tube defects. Cell Death Dis. Oct. 15, 2020;11(10):859. [cited by applicant]
Casey et al., Intrinsic DNA binding properties demonstrated for lineage-specifying basic helix-loop-helix transcription factors. Genome Res. Apr. 2018;28(4):484-496. doi: 10.1101/gr.224360.117. Epub Mar. 2, 2018. [cited by applicant]
Ikuno et al., Correction: efficient and robust differentiation of endothelial cells from human induced pluripotent stem cells via lineage control with VEGF and cyclic AMP. PLoS One. Apr. 17, 2017;12(4):e0176238. Erratum… [cited by applicant]
Kim et al., Selective depletion of SSEA-3- and TRA-1-60-Positive undifferentiated human embryonic stem cells by magnetic activated cell sorter (MACS). Tissue Eng. and Regen. Med. 2011;8(2): 253-261. [cited by applicant]
Klum et al., Sequentially acting SOX proteins orchestrate astrocyte- and oligodendrocyte-specific gene expression. EMBO Rep. Nov. 2018;19(11):e46635. Epub Aug. 30, 2018. [cited by applicant]
Kojo et al., Priming of lineage-specifying genes by Bcl1 1b is required for lineage choice in post-selection thymocytes. Nat Commun. Sep. 26, 2017;8(1):702. doi: 10.1038/s41467-017-00768-1. [cited by applicant]
Ng et al., A comprehensive library of human transcription factors for cell fate engineering. Nat Biotechnol. Apr. 2021;39(4):510-519. Epub Nov. 30, 2020. Author Manuscript, 37 pages. [cited by applicant]
Oestreich et al., Master regulators or lineage-specifying? Changing views on CD4+ T cell transcription factors. Nat Rev Immunol. Nov. 2012;12(11):799-804. doi: 10.1038/nri3321. Epub Oct. 12, 2012. Author Manuscript, 13 … [cited by applicant]
Patsch et al., Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells. Nat Cell Biol. Aug. 2015;17(8):994-1003. Epub Jul. 27, 2015. Supplementary Information, 9 pages. [cited by applicant]
Pozniak et al., Sox10 directs neural stem cells toward the oligodendrocyte lineage by decreasing Suppressor of Fused expression. Proc Natl Acad Sci U S A. Dec. 14, 2010;107(50):21795-800. Epub Nov. 22, 2010. [cited by applicant]
Rufaihah et al., Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity. Am J Transl Res. 2013;5(1):21-35. Epub Jan. 21, 2013. [cited by applicant]
Ryu et al., Gene therapy of multiple sclerosis using interferon β-secreting human bone marrow mesenchymal stem cells. Biomed Res Int. 2013;2013:696738. Epub Apr. 22, 2013. [cited by applicant]
Sarkar et al., The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell. Jan. 3, 2013;12(1):15-30. [cited by applicant]
Ahlenius et al., Rapid and efficient induction of functional astrocytes from human pluripotent stem cells. Protocol Exchange. Aug. 20, 2018;(1). doi: 10.1038/protex.2018.088. 6 pages. [cited by applicant]
Michael et al., Cooperation between bHLH transcription factors and histones for DNA access. Nature. Jul. 2023;619(7969):385-393. doi: 10.1038/s41586-023-06282-3. Epub Jul. 5, 2023. Suppl Info, 33 pages. [cited by applicant]
Tanaka et al., Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro. PLoS One. Apr. 23, 2013;8(4):e61540. doi: 10.1371/journal.pone.0061540. [cited by applicant]
Wang et al., MyoD is a 3D genome structure organizer for muscle cell identity. Nat Commun. Jan. 11, 2022;13(1):205. doi: 10.1038/s41467-021-27865-6. [cited by applicant]